Katsufumi Mizushige Selected Research

Phosphoric Diester Hydrolases (Phosphodiesterases)

1/2006

The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsufumi Mizushige Research Topics

Disease

3	Heart Failure 01/2006 - 01/2002
3	Coronary Stenosis (Coronary Artery Stenosis) 09/2003 - 04/2002
3	Type 2 Diabetes Mellitus (MODY) 09/2002 - 01/2002
2	Stroke (Strokes) 01/2011 - 09/2004
2	Myocardial Infarction 03/2005 - 08/2002
2	Insulin Resistance 01/2002 - 01/2002
1	Mitral Valve Prolapse 01/2011
1	Fibrosis (Cirrhosis) 02/2007
1	Diastolic Heart Failure 06/2006
1	Body Weight (Weight, Body) 05/2006
1	Cardiotoxicity 05/2006
1	Cardiac Arrhythmias (Arrythmia) 01/2006
1	Cerebral Infarction 09/2004
1	Diabetes Mellitus 08/2004
1	Glucose Intolerance 08/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2004
1	Syncope (Fainting) 01/2004
1	Pathologic Constriction (Stenosis) 09/2003
1	Atrial Fibrillation 07/2003
1	Coronary Occlusion 07/2003
1	Vascular System Injuries 04/2003
1	Hyperemia 11/2002
1	Aortic Valve Insufficiency (Aortic Regurgitation) 09/2002
1	Arteriosclerosis 01/2002

Drug/Important Bio-Agent (IBA)

3	olprinoneIBA 01/2006 - 01/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2006 - 03/2005
2	Uncoupling Protein 2IBA 03/2005 - 09/2002
2	Glucose (Dextrose)FDA LinkGeneric 11/2002 - 01/2002
2	Pioglitazone (Actos)FDA Link 09/2002 - 01/2002
1	GenisteinIBA 02/2007
1	daidzeinIBA 02/2007
1	IsoflavonesIBA 02/2007
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2006
1	Angiotensin IIIBA 06/2006
1	SaltsIBA 06/2006
1	NADP (NADPH)IBA 06/2006
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2006
1	Phosphocreatine (Neoton)IBA 05/2006
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2006
1	Thiobarbituric Acid Reactive SubstancesIBA 05/2006
1	Adenosine Triphosphate (ATP)IBA 05/2006
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2006
1	Phosphodiesterase 3 InhibitorsIBA 01/2006
1	Acetazolamide (Diamox)FDA LinkGeneric 09/2004
1	CytokinesIBA 08/2004
1	Coenzyme A (CoA)IBA 08/2004
1	Oxidoreductases (Dehydrogenase)IBA 08/2004
1	Pravastatin (Pravachol)FDA LinkGeneric 08/2004
1	AcidsIBA 03/2004
1	Thallium-201IBA 03/2004
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2004
1	FS 069 (Optison)FDA Link 09/2003
1	Contrast MediaIBA 09/2003
1	Pharmaceutical PreparationsIBA 07/2003
1	Simvastatin (Zocor)FDA LinkGeneric 07/2003
1	UbiquinoneIBA 07/2003
1	Adenosine (Adenocard)FDA LinkGeneric 07/2003
1	Vasodilator Agents (Vasodilators)IBA 06/2003
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 04/2003
1	Coloring Agents (Dyes)IBA 11/2002
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2002
1	Perindopril FDA LinkGeneric 09/2002
1	Mitochondrial Uncoupling ProteinsIBA 09/2002
1	Insulin (Novolin)FDA Link 09/2002
1	SHU 508 (Levovist)IBA 08/2002
1	ThalliumIBA 08/2002
1	Dipyridamole (Persantine)FDA LinkGeneric 04/2002
1	AntioxidantsIBA 01/2002
1	EicosanoidsIBA 01/2002
1	Vitamin E FDA LinkGeneric 01/2002
1	Troglitazone (Rezulin)FDA Link 01/2002
1	8-epi-prostaglandin F2alphaIBA 01/2002
1	ThiazolidinesIBA 01/2002

Therapy/Procedure

2	Therapeutics 01/2011 - 01/2006
2	Microbubbles 04/2003 - 08/2002
1	Ligation 03/2005
1	Intravenous Infusions 04/2003
1	Microspheres (Microsphere) 11/2002